Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients.
Muendlein A, Geiger K, Heinzle C, Gaenger S, Winder T, Severgnini L, Reimann P, Brandtner EM, Leiherer A, Drexel H, Decker T, Nonnenbroich C, Dechow T.
Muendlein A, et al. Among authors: gaenger s.
J Cancer Res Clin Oncol. 2023 Aug;149(9):6435-6444. doi: 10.1007/s00432-023-04623-3. Epub 2023 Feb 10.
J Cancer Res Clin Oncol. 2023.
PMID: 36763171